Free tool
Stocks listed on Nasdaq GS
We cover 68 companies listed on Nasdaq GS. The median market value in the group is $12.87B. Across the group, the median move over the past trading day is −0.26%. 69% of the 67 with a 200-day average trade above it. Price change over the past year runs from −44.6% to +160.2% across the middle 80 percent of the group, with a median of +29.5%.
Other lists in this group
Table
68 of 1,279 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% |
| GILD | Gilead Sciences, Inc. | $184.47B | Large cap | +32.51% |
| VRTX | Vertex Pharmaceuticals Incorporated | $138.63B | Large cap | +40.66% |
| ISRG | Intuitive Surgical, Inc. | $133.22B | Large cap | −21.38% |
| SNY | Sanofi | $108.83B | Large cap | −4.33% |
| REGN | Regeneron Pharmaceuticals, Inc. | $83.89B | Large cap | +39.36% |
| ARGX | argenx SE | $65.51B | Large cap | +47.90% |
| MRNA | Moderna, Inc. | $59.75B | Large cap | +496.25% |
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.59% |
| MDLN | Medline Inc. | $46.53B | Large cap | −13.07% |
| RVMD | Revolution Medicines, Inc. | $46.18B | Large cap | +466.35% |
| IDXX | IDEXX Laboratories, Inc. | $43.66B | Large cap | −13.64% |
| ONC | BeOne Medicines AG | $42.58B | Large cap | +25.21% |
| RPRX | Royalty Pharma plc | $35.71B | Large cap | +74.00% |
| ILMN | Illumina, Inc. | $33.95B | Large cap | +125.88% |
| DXCM | DexCom, Inc. | $33.65B | Large cap | +16.47% |
| GEHC | GE HealthCare Technologies Inc. | $33.35B | Large cap | −1.15% |
| BIIB | Biogen Inc. | $32.66B | Large cap | +62.12% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $32.12B | Large cap | −47.38% |
| BNTX | BioNTech SE | $28.28B | Large cap | +9.27% |
| INSM | Insmed Incorporated | $27.16B | Large cap | −7.54% |
| ROIV | Roivant Sciences Ltd. | $26.55B | Large cap | +206.51% |
| INCY | Incyte Corporation | $25.97B | Large cap | +51.01% |
| GH | Guardant Health, Inc. | $22.94B | Large cap | +169.17% |
| GMAB | Genmab A/S | $21.42B | Large cap | +36.20% |
| VTRS | Viatris Inc. | $19.35B | Large cap | +66.19% |
| MEDP | Medpace Holdings, Inc. | $17.28B | Large cap | +30.74% |
| JAZZ | Jazz Pharmaceuticals plc | $16.89B | Large cap | +100.35% |
| ASND | Ascendis Pharma A/S | $16.41B | Large cap | +29.66% |
| NBIX | Neurocrine Biosciences, Inc. | $15.92B | Large cap | +13.36% |
| BBIO | BridgeBio Pharma, Inc. | $15.52B | Large cap | +60.05% |
| COO | The Cooper Companies, Inc. | $14.25B | Large cap | −1.93% |
| EXEL | Exelixis, Inc. | $14.05B | Large cap | +45.68% |
| ICLR | ICON Public Limited Company | $13.03B | Large cap | −2.91% |
| BMRN | BioMarin Pharmaceutical Inc. | $12.70B | Large cap | +11.85% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $12.52B | Large cap | +308.99% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $12.45B | Large cap | +26.78% |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | +46.30% |
| TEM | Tempus AI, Inc. | $12.40B | Large cap | −6.49% |
| TECH | Bio-Techne Corporation | $11.35B | Large cap | +29.33% |
| BTSG | BrightSpring Health Services, Inc. | $11.32B | Large cap | +156.37% |
| ALGN | Align Technology, Inc. | $11.31B | Large cap | +12.09% |
| CYTK | Cytokinetics, Incorporated | $11.01B | Large cap | +109.36% |
| KRYS | Krystal Biotech, Inc. | $10.65B | Large cap | +143.67% |
| IONS | Ionis Pharmaceuticals, Inc. | $10.56B | Large cap | +48.21% |
| PRAX | Praxis Precision Medicines, Inc. | $10.54B | Large cap | +704.28% |
| ENSG | The Ensign Group, Inc. | $10.43B | Large cap | +5.01% |
| HSIC | Henry Schein, Inc. | $10.30B | Large cap | +31.02% |
| RGEN | Repligen Corporation | $10.25B | Large cap | +51.67% |
| ATRA | Atara Biotherapeutics, Inc. | $94.15M | Micro cap | −24.05% |
| CVRX | CVRx, Inc. | $87.12M | Micro cap | −56.75% |
| GOSS | Gossamer Bio, Inc. | $85.01M | Micro cap | −92.93% |
| DH | Definitive Healthcare Corp. | $84.34M | Micro cap | −80.44% |
| OM | Outset Medical, Inc. | $79.89M | Micro cap | −69.56% |
| PLRX | Pliant Therapeutics, Inc. | $73.69M | Micro cap | −31.36% |
| SPRO | Spero Therapeutics, Inc. | $71.05M | Micro cap | −38.38% |
| XBIT | XBiotech Inc. | $70.43M | Micro cap | −33.62% |
| PMVP | PMV Pharmaceuticals, Inc. | $70.03M | Micro cap | −7.75% |
| BOLD | Boundless Bio, Inc. | $66.31M | Micro cap | +155.70% |
| MCRB | Seres Therapeutics, Inc. | $47.81M | Micro cap | −74.79% |
| MGX | Metagenomi Therapeutics, Inc. | $46.09M | Micro cap | −34.41% |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | $44.46M | Micro cap | −74.90% |
| PETS | PetMed Express, Inc. | $38.81M | Micro cap | −43.35% |
| KYNB | Kyntra Bio, Inc. | $32.82M | Micro cap | −22.66% |
| QNCX | Quince Therapeutics, Inc. | $31.84M | Micro cap | +100.71% |
| NXTC | NextCure, Inc. | $27.05M | Micro cap | +11.37% |
| TXMD | TherapeuticsMD, Inc. | $26.39M | Micro cap | +103.57% |
| TRIB | Trinity Biotech plc | $7.80M | Micro cap | +547.97% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.